CP
IBB icon

Creekside Partners’s iShares Biotechnology ETF IBB Stock Holding History

Creekside Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$611K Buy
3,617
+1
+0% +$171 0.25% 86
2025
Q4 		$610K Buy
3,616
+2
+0.1% +$325 0.26% 82
2025
Q3 		$522K Sell
3,614
-231
-6% -$31.5K 0.23% 94
2025
Q2 		$486K Hold
3,845
– – 0.23% 94
2025
Q1 		$492K Buy
3,845
+2
+0.1% +$271 0.26% 87
2024
Q4 		$508K Buy
3,843
+141
+4% +$19.8K 0.26% 86
2024
Q3 		$539K Buy
3,702
+2
+0.1% +$289 0.28% 85
2024
Q2 		$508K Buy
+3,700
New +$494K 0.28% 83

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Creekside Partners's IBB Position: Q1 2026 in Review

Creekside Partners increased its iShares Biotechnology ETF (IBB) stake by 0.03% in Q1 2026, buying an estimated $171 and bringing the position to 3,617 shares worth $611K. The position accounts for 0.25% of the portfolio, ranked #86.

Creekside Partners first reported a position in IBB in Q2 2024 and has held it in 8 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Creekside Partners held 3,617 shares of iShares Biotechnology ETF worth $611K as of Q1 2026.
  • Creekside Partners bought 1 iShares Biotechnology ETF share in Q1 2026, an estimated $171.
  • iShares Biotechnology ETF made up 0.25% of Creekside Partners's portfolio in Q1 2026, its #86 holding.
  • Creekside Partners first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 8 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Creekside Partners's 13F filing for Q1 2026, filed 22 Apr 2026.